Collegium Pharmaceutical Inc logo

Collegium Pharmaceutical Inc

$ 22.40 -0.33 (-1.45%) 10:08 PM EST
P/E:
At Loss
P/B:
3.84
Market Cap:
$ 752.01M
Enterprise V:
$ 1.36B
Volume:
225.25K
Avg Vol (2M):
215.76K
Also Trade In:
Volume:
225.25K
Market Cap $:
752.01M
PE Ratio:
At Loss
Avg Vol (2-Month):
215.76K
Enterprise Value $:
1.36B
PB Ratio:
3.84
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Financials (Next Earnings Date:2023-02-24 Est.)

COLL's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:COLL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 361.675
EPS (TTM) ($) -1.26
Beta 0.74
Volatility % 39.56
14-Day RSI 63.79
14-Day ATR ($) 0.820737
20-Day SMA ($) 21.313
12-1 Month Momentum % 3.69
52-Week Range ($) 14.04 - 23.27
Shares Outstanding (Mil) 33.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Collegium Pharmaceutical Inc Filings

Document Form Filing Date
No Filing Data

Collegium Pharmaceutical Inc Analysis

Share your research

Headlines

See More
No news.